Abstract
Establishing the appropriate yet minimal number of control mice for experiments is a critical step in experimental design. This decision is particularly important regarding the study of the hematopoietic system over time, given various age-associated changes in murine hematopoietic cell populations. Here we used flow cytometry to serially monitor the frequencies of hematopoietic stem cells, common lymphoid progenitor cells, and common myeloid progenitor cells and RT-PCR assays to study the levels of Ly6a(Sca1), Slamf1, Ikzf1, and Cebpa—4 genes that control the hematopoietic process—in wildtype male and female mice with a B6SJL genetic background. These analyses revealed many differences, both at the cellular and mRNA levels, between immature and mature mice at various developmental stages. In conclusion, although it is necessary to minimize the number of mice possible insofar as possible to reduce animal use and meet animal welfare requirements, the numerous differences shown by our findings highlight the need to establish controls for every time point selected for the study of the hematopoietic system cells. This need is especially crucial when comparing immature and mature stages of mouse development.
Abbreviations: CLP, common lymphoid progenitor; CMP, common myeloid progenitor; HSC, hematopoietic stem cell; HSPC, hematopoietic stem and progenitor cell
The establishment of optimal numbers of animals for experiments continues to be an important issue in biomedical research. Differences due to sex-related factors as well as the natural maturity and aging process can arise and thus complicate the selection of the appropriate sex balance and number of the animals for research studies.4,17,19
Many of the studies of the hematopoietic system have involved mice. At the top of the hematopoietic hierarchy are hematopoietic stem cells (HSC); these multipotent cells are self-renewing and give rise to every type of blood cell. Their closest progeny are hematopoietic progenitor cells, specifically the common lymphoid progenitors (CLP) and common myeloid progenitors (CMP), which are oligopotent cells with limited self-renewal capacity. CLP and CMP give rise to the lymphoid and myeloid lineages, respectively.8,22,25 Collectively HSC and hematopoietic progenitor cells are known as hematopoietic stem and progenitor cells (HSPC) and are responsible for hematopoietic homeostasis. HSPC also have an important role in pathologic conditions, by rapidly supplying hematopoietic progenitor cells which can, in turn, give rise to numerous specialized immune cells.21,22
Regulation of hematopoiesis is orchestrated through many genes, including Ly6A(Sca1), Slamf1, Ikzf1, and Cebpa. Ly6a plays an essential role in the regulation of the HSC cycle and the commitment of these cells to become hematopoietic progenitors.6 Slamf1 is highly expressed in the subpopulation of long-term HSC, which have increased self-renewal potential and are prone to commit to the myeloid lineage.3 Ikzf1 expression is necessary for the commitment of multipotent progenitor cells to the lymphoid lineage (that is, it controls lymphopoiesis),24 whereas Cebpa instructs multipotent progenitor cells to differentiate toward the myeloid lineage.26 In this way, Ikzf1 and Cebpa act as ‘switches’ for lineage commitment.
Many studies have addressed the variations in the immune system throughout the embryonic development and aging of mice, but little has been studied regarding the progression from postnatal immature stages to adulthood and even less about the steps involved during the maturation of HSPC. For example, T cells are known to be present in low numbers immediately after birth2 and that their population increases as the thymus develops and increases the output of naïve T cells.11 After a while, however, T cells numbers begin to diminish in number and function over time, due to the inexorable involution of thymus, which starts at a young age (around sexual maturity or even earlier) in both humans and mice.13 In addition, as the mice age, HSC show a decrease in their self-renewal capacity but an increase in frequency and bias toward differentiation along the myeloid lineage, to the detriment of lymphoid lineage progenitors and mature lymphocytes.11,14 In comparison, in both humans and mice, myeloid cells are present at high frequency during the first weeks after birth, due to the migration of these cells to colonize lymphoid and nonlymphoid tissues, particularly the gastrointestinal tract, where they exert a vital role in the establishment of the microbiota.12,23 Once this process is complete and the animal is close to sexual maturity, myeloid cell frequencies stabilize, and the size of this population decreases compared with its size at the immature stage.
The aim of the current study was to investigate the frequencies of HSC, CLP, and CMP under physiologic conditions in immature and mature wild-type mice with a B6SJL background, to assess the need for time-point–specific experimental controls. To this end, we collected serial blood samples for analysis of these cell populations by flow cytometry. In addition, we used RT-PCR assays to evaluate the expression profiles of 4 genes important in the hematopoietic process—Ly6A(Sca1), Slamf1, Ikzf1, and Cebpa.
Materials and Methods
Animals.
Wild-type mice on a B6SJL genetic background (B6SJL-Tg(SOD1-G93A)1Gur/J; The Jackson Laboratory, Bar Harbor, ME) were used for this study. Pelleted food (no. 2914 for maintenance and no. 2918 for breeders, Harlan Laboratories, Indianapolis, IN) and tap water were provided without restriction. Mice were housed in IVC (Tecniplast, Buguggiate, Italy) under a 12:12-h light cycle at the Unidad Mixta de Investigación (University of Zaragoza, Spain). Ambient conditions included a room temperature of 21 to 23 °C and a relative humidity of 55%. Cages contained bedding (Lignocel Select Fine for maintenance and ARBOCEL Performance Small for breeders, Rettenmaier Ibérica, Barcelona, Spain) but no other enrichment items. The mice were routinely screened (IDEXX, Westbrook, ME) for bacterial, viral, and parasitic pathogens according to FELASA guidelines and by using standard procedures (Figure 1). All experimental procedures were approved by the Ethics Committee for Animal Experiments of the University of Zaragoza. Animal care and experimentation were performed according to the Spanish Policy for Animal Protection RD53/2013, which meets the European Union Directive 2010/63/UE. The methodology enabled accurate characterization of the cells in small volumes of whole blood, which is in accordance with previous studies.7 Notwithstanding, we did not test any mice younger than 30 d, to avoid undue stress during the first weeks of life and possible developmental effects.
Figure 1.
Pathogens monitored through annual testing of mouse colonies.
Blood extraction and flow cytometry.
For the flow cytometry study, 30 wildtype B6SJL (15 male and 15 female) were used. Serial blood samples were collected on postnatal days 30, 50, 75, 105, and 120. The selected ages correspond to various development milestones in mice. The tails of the mice were exposed to an infrared light for 5 min to dilate the veins. The tail skin was disinfected with alcohol, and blood was collected by puncturing one of the lateral tail veins by using a 25-gauge needle and collecting the blood into capillary tubes containing EDTA (Microvette CB 300, Sarstedt, Nümbrecht, Germany). The amount of blood collected ranged between 20 and 100 µL. For identification of HSC, samples were stained with antibodies to CD3 (clone 17A2), CD45R (B220), CD11b (m1/70) TER119, and LyG6/Gr1 (RB6-C5) (Mouse Hematopoietic Lineage eFluor 450 Cocktail, eBioscience, San Diego, CA), Ly6A/E (Sca1; PE-conjugated, eBioscience), and CD117 (c-kit) (APC-conjugated, eBioscience). To differentiate CMP from CLP, samples were stained with PE–Cy7-conjugated antiCD127 (IL7RA) antibody (BD Biosciences, Franklin Lakes, NJ). Erythrocytes were lysed, and samples were analyzed by flow cytometry (Gallios Flow Cytometer, Beckman Coulter, Brea, CA); resulting data were analyzed by using Kaluza Flow Analysis Software (Beckman Coulter) and exported to a spreadsheet (Excel, Microsoft, Redmond, WA). Compensation controls were run for each antibody to correct spectral overlap.
Real-time PCR analysis.
For real-time PCR analysis, 8 wildtype B6SJL mice (4 male and 4 female) per time point (age, 30, 50, 75, 105, and 120 d) were euthanized by CO2 anesthesia, and blood obtained by cardiocentesis was collected into 2-mL EDTA tubes. Total RNA was extracted (Purelink Total RNA Blood Purification Kit, Invitrogen, Life Technologies; Waltham, MA) from each sample, treated with DNAse (Turbo DNA-free Kit, Ambion, Life Technologies, Waltham, MA) to eliminate genomic DNA, and reverse-transcribed (SuperScript First-Strand Synthesis System kit, Invitrogen). Probes for Ly6a(Sca1) (catalog no. m00726565_s1), Slamf1 (Mm00443316_m1), Ikzf1 (Mm01187882_m1), and Cebpa (Mm00514283_s1) were obtained from Applied Biosystems (Life Technologies, Foster City, CA). The endogenous gene Gapdh (Mm03302249_g1; probe from Applied Biosystems) was used to normalize the data.
Statistics.
Data were analyzed by using SPSS Statistics version 19.0 (IBM, Armonk, NY). Changes in gene expression and cell frequencies throughout the animal development were assessed by using repeated-measures ANOVA after checking the normality assumption by using the Kolmogórov–Smirnov test, and the corresponding Bonferroni posthoc test was used to analyze specific differences between the time points. The data are presented as mean ± SEM (error bars). A Pvalue less than 0.05 was used to define statistical significance.
Results
HSPC profiles at various stages of sexual maturity in mice.
Our first step was to use flow cytometry to study HSC, CLP, and CMP profiles in serial blood samples obtained from immature (postnatal days 30 and 50) and mature (days 75, 105, and 120) mice; sexual maturity in laboratory mice is considered to between days 45 to 60.18 Flow cytometry results revealed that most of the differences were set between the immature and the mature stages of mice development (Figure 2). HSC frequencies at days 30 and 50 (which did not differ from each other) both were greater than those at each later time point (Bonferroni P < 0.001 for all cases; Figure 2 A). Differences in CLP frequencies were similar in magnitude but showed the opposite relationship, as CLP percentages were lower at 30 and 50 d and dramatically increased at 75 d followed by a gradual decrease over later time points (Bonferroni Pbetween days 30 and 75, P < 0.05; between days 30 and 120, 50 and 75, and 50 and 105: P < 0.001; Figure 2 B). For CMP, the inflection point occurred at day 75 and was therefore slightly delayed relative to those of HSC and CLP (day 50; Bonferroni Pbetween days 50 and 120, P < 0.01; between days 30 and 105, 30 and 120, and 50 and 105: P < 0.001; Figure 2 C).
Figure 2.
Flow cytometric analysis of HSPC frequencies (%; mean ± SEM) in the peripheral blood of mice at postnatal day (P) 30, 50, 75, 105, and 120 d. HSC were identified as being Lin–Sca1+c-Kit+; CLP were Lin–Sca1lowc-KitlowCD127+; and CMP were Lin–Sca1–c-Kit+CD127–. (A) HSC percentages. (B) CLP percentages. (C) CMP percentages. Different lowercase letters indicate significantly (P< 0.05) different values; n = 30 (15 male and 15 female, monitored serially).
In addition to the differences between immature and mature time points, HSC profiles within each developmental stage differed. The percentages of CLP and CMP decreased slightly (Bonferroni P < 0.001) between days 30 and 50 (Figure 2 B and C). Regarding the later time points, mature stages, HSC frequency decreased slightly (Bonferroni p < 0.05) from 75 to 105, followed by slight increase (Bonferroni P < 0.001) between days 105 and 120 (Figure 2 A). In contrast, both CLP and CMP consistently decreased from day 75 to 120 (Bonferroni P< 0.001for both CLP comparisons; Bonferroni P < 0.01 for both CMP comparisons).
mRNA expression profile.
We next assessed whether the mRNA expression profiles of genes important in the control of hematopoiesis followed similar trends to those observed at the cellular level. mRNA levels of Ly6a(Sca1) and Slamf1 l showed similar patterns to those of HSC and CLP frequency, with expression levels differing mainly between immature and mature stages (Figure 3 A and B). Expression levels of Ikzf1 and Cebpa tended to parallel CLP and CMP frequency trends in immature mice but sometimes differed from population data in mature mice (Figure 3 C and D).
Figure 3.
RT-PCR analysis of circulating mRNA transcript levels (cycle threshold [ΔCt] value; mean ± SEM) of (A) Ly6a(Sca1), (B) Slamf1,(C) Ikzf1,and(D) Cebpa in mice at postnatal days (P) 30, 50, 75, 105, and 120. Different lowercase letters indicate significantly (P< 0.05) different values; n = 40 in total, 4 male and 4 female at each time point.
Regarding differences in transcription levels at various time points within a developmental stage, Ly6a(Sca1) was the only gene to show differences (Bonferroni P < 0.05) in immature mice (that is, between days 30 and 50). With regard to mature mice, all 4 genes showed differences in expression between days 75, 105, and 120. Ly6a(Sca1) transcript levels differed between days 105 and 120 (Bonferroni P < 0.05); Slamf1 between days 75 and 105 and days 105 and 120 (Bonferroni P < 0.001 for both comparison); Ikzf1 between days 75 and 105 (Bonferroni P < 0.05) and days 75 and 120 (Bonferroni P < 0.01); and Cebpa expression differed between days 75 and 105 (Bonferroni P < 0.01) and days 105 and 120 (Bonferroni P < 0.05).
Discussion
Our flow cytometric results revealed that, overall, the HSC, CLP, and CLM profiles of immature mice differed from those of mature mice (Figure 2). The inflection point of cell frequencies was set between days 50 and 75, with HSC being higher at the immature stage and then decreasing and CLP and CMP percentages acting in the opposite way. Our HSC data are in accordance with studies showing that the frequency of HSC is higher during the immature stages of fast development and declines once the mice reach maturity.9 Whereas the point of inflection was day 50 for CLP as for HSC, that for CMP was delayed slightly, to day 75. The different inflection times for CLP and CMP might reflect the adjustment of the immune system to the process of developmental maturation, given that members of the myeloid lineage are more prominent and numerous than are those of the lymphoid lineage at the immature stages of hematopoietic development. Myeloid-derived suppressor cells are known to be abundant in young mice and have a prominent role in modulating the early immune response,16 thus perhaps explaining the delayed decrease in CMP frequency that we observed. In addition, the higher frequency of CMP in immature mice could be due to the continued circulation of these cells in the blood to colonize lymphoid and nonlymphoid tissues; unlike that in humans, this colonization is not completed before birth in mice.12 Finally, during the first weeks after birth, the gastrointestinal tract is colonized by the microbiota, thereby providing another possible explanation for the increased presence of circulating CMP, given that their mature progeny are important in the early acquisition of tolerance to the microbiota.1 In contrast, CLP were decreased in frequency at early experimental time points, perhaps owing to the generally immature state of the lymphoid system at birth and during the first weeks of life.2 Once mice became mature, however, the lymphoid lineage inverted the CMP–CLP relationship, and CLP reached much higher frequencies before decreasing over time. This decrease was observed previously in 7-mo-old mice, in which the CLP frequency in the bone marrow was decreased, seemingly due to the diminished lymphopoietic potential of the HSC and perhaps also reflecting defects in the survival or proliferative potential of CLP themselves.20
Regarding our study of the mRNA expression patterns of 4 genes related to the hematopoietic system function (Figure 3), Ly6a(Sca1) and Slamf1 transcript levels were similar in overall pattern to the evolution of HSC and CLP frequencies, with marked differences in immature compared with mature mice. Given that these 2 genes regulate HSC function and their commitment to lineage progenitors, similar trends between their expression and the frequency of these cells was logical.3,6,10 Ikzf1 and Cebpa expression trends were similar to those of Ly6a(Sca1) and Slamf1 in immature but not mature mice. CLP frequency decreased from day 75, but Ikzf1 expression levels did not precisely follow this pattern. In addition, Cebpa levels at days 105 and 120 deviated from the population findings, in that CMP frequency was lower at these 2 time points compared with earlier points. Ikzf1 and Cebpa are essential in the commitment of multipotent progenitor cells to either the lymphoid or myeloid lineage, respectively.5,15,26 The parallel increases in Ikzf1 and Cebpa expression levels and CLP and CMP populations in immature mice is in accordance with their function and with the frequencies observed for these cells. The similarities between the mRNA profiles and the cell frequencies might reflect the activation of these genes to promote the proliferation of the cells in which they play a prominent role, at least early during development.
The findings obtained from our flow cytometric and RT-PCR analyses of hematopoietic cells and genes reveal the need to establish an appropriate population of control animals at each of the specific age points selected for an experiment. Although minimizing the number of control animals is laudable, using a single control group for an overall developmental stage (for example, immature and mature) is in appropriate for hematopoiesis research, given the rapid variation in the HSPC profile throughout development process (as little as 25 d, in the case of the differences found between the 50- and 75-d time points). Just as the maximal number of animals used as controls should minimized, it is mandatory to establish an appropriate minimal number of controls for every time point selected in the study of the hematopoietic system to ensure the validity of research results.
Acknowledgments
This work was supported by Grant FIS (PI14/00947), Instituto de Salud Carlos III, and FEDER Funds. We thank Miriam de la Torre, Silvia Garcés, and Pilar Lierta for their expert technical assistance.
References
- 1.Abt MC, Osborne LC, Monticelli LA, Doering TA, Alenghat T, Sonnenberg GF, Paley MA, Antenus M, Williams KL, Erikson J, Wherry EJ, Artis D. 2012. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37:158–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Adkins B, Leclerc C, Marshall-Clarke S. 2004. Neonatal adaptive immunity comes of age. Nat Rev Immunol 4:553–564. [DOI] [PubMed] [Google Scholar]
- 3.Beerman I, Bhattacharya D, Zandi S, Sigvardsson M, Weissman IL, Bryder D, Rossi DJ. 2010. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 107:5465–5470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Beery AK, Zucker I. 2011. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 35:565–572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bottardi S, Mavoungou L, Milot E. 2015. IKAROS: a multifunctional regulator of the polymerase II transcription cycle. Trends Genet 31:500–508. [DOI] [PubMed] [Google Scholar]
- 6.Bradfute SB, Graubert TA, Goodell MA. 2005. Roles of Sca1 in hematopoietic stem–progenitor cell function. Exp Hematol 33:836–843. [DOI] [PubMed] [Google Scholar]
- 7.Breslin WL, Strohacker K, Carpenter KC, Haviland DL, McFarlin BK. 2013. Mouse blood monocytes: standardizing their identification and analysis using CD115. J Immunol Methods 390:1–8. [DOI] [PubMed] [Google Scholar]
- 8.Bryder D, Rossi DJ, Weissman IL. 2006. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 169: 338–346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Copley MR, Eaves CJ. 2013. Developmental changes in hematopoietic stem cell properties. Exp Mol Med 45:e55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Chen MJ, Li Y, De Obaldia ME, Yang Q, Yzaguirre AD, Yamada-Inagawa T, Vink CS, Bhandoola A, Dzierzak E, Speck NA. 2011. Erythroid, myeloid progenitor, and hematopoietic stem cells originate from distinct populations of endothelial cells. Cell Stem Cell 9:541–552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Chinn IK, Blackburn CC, Manley NR, Sempowski GD. 2012. Changes in primary lymphoid organs with aging. Semin Immunol 24:309–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.De Kleer I, Willems F, Lambrecht B, Goriely S. 2014. Ontogeny of myeloid cells. Front Immunol 5:423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dixit VD. 2012. Impact of immune–metabolic interactions on age-related thymic demise and T cell senescence. Semin Immunol 24:321–330. [DOI] [PubMed] [Google Scholar]
- 14.Farrell TL, McGuire TR, Bilek LD, Brusnahan SK, Jackson JD, Lane JT, Garvin KL, O'Kane BJ, Berger AM, Tuljapurkar SR, Kessinger MA, Sharp JG. 2013. Changes in the frequencies of human hematopoietic stem and progenitor cells with age and site. Exp Hematol 42:146–154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Friedman AD. 2015. C/EBPα in normal and malignant myelopoiesis. Int J Hematol 101:330–341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gantt S, Gervassi A, Jaspan H, Horton H. 2014. The role of myeloid-derived suppressor cells in immune ontogeny. Front Immunol 5:387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. 2007. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 22:1197–1207. [DOI] [PubMed] [Google Scholar]
- 18.Jackson Laboratory. [Internet] 2009. Breeding strategies for maintaining colonies of laboratory mice: a Jackson Laboratory resource manual. [Cited 20 February 2016]. Available at: http://www.research.uci.edu/forms/docs/iacuc/JAX-breeding-strategies.pdf.
- 19.Lamberty Y, Gower AJ. 1990. Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age. Physiol Behav 47:1137–1144. [DOI] [PubMed] [Google Scholar]
- 20.Linton PJ, Dorshkind K. 2004. Age-related changes in lymphocyte development and function. Nat Immunol 5:133–139. [DOI] [PubMed] [Google Scholar]
- 21.Massberg S, von Andrian UH. 2009. Novel trafficking routes for hematopoietic stem and progenitor cells. Ann N Y Acad Sci 1176:87–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mazo IB, Massberg S, von Andrian UH. 2011. Hematopoietic stem and progenitor cell trafficking. Trends Immunol 32:493–503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Renz H, Brandtzaeg P, Hornef M. 2011. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 12:9–23. [DOI] [PubMed] [Google Scholar]
- 24.Schwickert TA, Tagoh H, Gultekin S, Dakic A, Axelsson E, Minnich M, Ebert A, Werner B, Roth M, Cimmino L, Dickins RA, Zuber J, Jaritz M, Busslinger M. 2014. Stage-specific control of early B cell development by the transcription factor Ikaros. Nat Immunol 15:283–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Shizuru JA, Negrin RS, Weissman IL. 2005. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 56:509–538. [DOI] [PubMed] [Google Scholar]
- 26.Wölfler A, Danen-van Oorschot AA, Haanstra JR, Valkhof M, Bodner C, Vroegindeweij E, van Strien P, Novak A, Cupedo T, Touw IP. 2010. Lineage-instructive function of C/EBPα in multipotent hematopoietic cells and early thymic progenitors. Blood 116:4116–4125. [DOI] [PubMed] [Google Scholar]



